Skip to main content

Advertisement

Association of CYPA1 gene polymorphism with plasma nitric oxide levels in COPD

Article metrics

  • 999 Accesses

Background

Chronic obstructive pulmonary disease (COPD) is characterized by irreversible airflow limitation, abnormal permanent distal air-space enlargement and emphysema in the lungs. Increased oxidative burden in COPD is because of both directly a result of smoking and indirectly by the release of increasing amount of ROS from airways leukocytes. The CYP1A1 gene modifies the phase I enzyme aryl hydrocarbon hydroxylase (AHH) belonging to the cytochrome P450 system that plays a major role in the metabolism of exogenous toxins generated by cigarette smoke [1]. The aim of the present study is to assess the role of CYP1A1 gene polymorphism and to measure the plasma nitric oxide levels in the etiology of COPD in South Indian Population from Andhra Pradesh.

Materials and methods

A cohort of 250 clinically and spirometrically confirmed COPD patients referred to Government Chest Hospital, Hyderabad and an equal member of age and sex matched control subjects were included in the present study. Genotyping of CYP1A1 gene polymorphism was done by PCR – RFLP method followed by agarose gel electrophoresis. The plasma nitrite levels were estimated by spectrophotometric method. Appropriate statistical methods were applied to test for the significance of the results.

Results

Genotypic distribution of CYP1A1 gene polymorphism revealed 36.8% of TT, 50.8% of TC and 12.4% of CC genotypes in COPD patients and 44.8% of TT, 48.4% of TC and 6.8% of CC in control subjects (Figure 1). There is an increased frequency of CC genotype and C allele in the COPD patients compared to control subjects (X2 = 4.51; p=0.03; OR=1.94; 95% CI = (1.044-3.605) and (X2=5.12; p=0.02; OR=1.35; 95% CI=(1.041-1.758). (Table 1). The study carried out from North Indian population have shown that CYP1A1,-3801 polymorphism was significantly associated with COPD [2]. The mean levels of plasma nitrite levels were also found to significantly elevated in COPD patients (2.715 ± 1.552) in comparison with their respective controls (1.123 ± 0.699) (p<0.001) (t value = 2.6449).

Figure 1
figure1

Agarose Gel Electrophoresis showing the Amplification of 340 bp, 200 bp and 140 bp product After Restriction enzyme digestion by (MspI).

Table 1 Comparison of genotypes and alleles of CYPA1-3801 T /C in COPD and Controls

Conclusions

The present study indicates the association of CYP1A1 gene polymorphism and plasma nitric oxide levels in the etiology of COPD patients of South Indian population from Andhra Pradesh.

References

  1. 1.

    Kiyohara C, Hirohata T, Inusuka S: The relationship between aryl hydrocarbon hydroxylase and polymorphisms of CYP1A1 gene. Jpn J Cancer Res. 1996, 87: 18-24.

  2. 2.

    Arpana Vibhuti, Ehtesham Arif, Aastha Mishra, Desh Deepak, Bhawani Singh, Irfan Rahman, Ghulam Mohammad: CYP1A1, CYP1A2 CYBA gene polymorphisms associated with oxidative stress in COPD. Clinica Chimica Acta. 2010, 411: 7-8. 474–480

Download references

Author information

Correspondence to Ashrafunnisa Begum.

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Keywords

  • Chronic Obstructive Pulmonary Disease
  • Chronic Obstructive Pulmonary Disease Patient
  • CYPA1 Gene
  • Cytochrome P450 System
  • Matched Control Subject